About the SHILLA(TM) Growth Guidance System
The SHILLA(TM) Growth Guidance System is indicated for skeletally immature patients less than 10 years of age with the potential for additional spinal growth, who require surgical treatment for correction and maintenance of the correction of severe, progressive, life-threatening early-onset deformities, including early-onset scoliosis, which are associated with or at risk of thoracic insufficiency syndrome. The SHILLA(TM) Growth Guidance System is intended to be removed after skeletal maturity. Every spinal surgical procedure involves risks. Patients should consult with their physicians to discuss the potential risks associated with this procedure. Patients need to know that not all spinal surgeries are successful. Adverse events such as implant loosening or breakage may occur, which could result in the need for further surgery.
About Medtronic's Spinal Business
Ad Statistics
Times Displayed: 113107
Times Visited: 6739 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Medtronic's spinal business, based in Memphis, Tenn., is the global leader in today's spine market and is committed to advancing the treatment of spinal conditions. Medtronic's spinal business collaborates with world-renowned surgeons, researchers and innovative partners to offer state-of-the-art therapies for spinal, neurological, orthopaedic and oral maxillofacial conditions. Medtronic is committed to developing affordable, minimally invasive procedures that provide lifestyle friendly surgical therapies. More information about spinal treatments can be found at its patient-education Web site, www.back.com.
About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts:
Victor Rocha
Public Relations
+1-901-399-2401
Jeff Warren
Investor Relations
+1-763-505-2696
Back to HCB News
